United Kingdom Artificial Intelligence In Diagnostics Market, Forecast to 2033

United Kingdom Artificial Intelligence In Diagnostics Market

United Kingdom Artificial Intelligence In Diagnostics Market By Component (Software, Hardware), By Application (Radiology, Pathology, Cardiology, Oncology), By End-User (Hospitals, Diagnostic Centers), By Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2026-2033

Report ID : 4614 | Publisher ID : Transpire | Published : Apr 2026 | Pages : 180 | Format: PDF/EXCEL

Revenue, 2025 USD 123.4 Million
Forecast, 2033 USD 641.69 Million
CAGR, 2026-2033 22.90%
Report Coverage United Kingdom

United Kingdom Artificial Intelligence In Diagnostics Market Size & Forecast:

  • United Kingdom Artificial Intelligence In Diagnostics Market Size 2025: USD 123.4 Million
  • United Kingdom Artificial Intelligence In Diagnostics Market Size 2033: USD 641.69 Million
  • United Kingdom Artificial Intelligence In Diagnostics Market CAGR: 22.90%
  • United Kingdom Artificial Intelligence In Diagnostics Market Segments: By Component (Software, Hardware), By Application (Radiology, Pathology, Cardiology, Oncology), By End-User (Hospitals, Diagnostic Centers).

United Kingdom Artificial Intelligence In Diagnostics Market Size

To learn more about this report,  PDF Icon Download Free Sample Report

United Kingdom Artificial Intelligence In Diagnostics Market Summary:

The United Kingdom Artificial Intelligence In Diagnostics Market size is estimated at USD 123.4 Million in 2025 and is anticipated to reach USD 641.69 Million by 2033, growing at a CAGR of 22.90% from 2026 to 2033. The United Kingdom Artificial Intelligence (AI) in Diagnostics market is experiencing strong expansion because there is growing demand for diagnostic systems which provide precise results within short timeframes at affordable prices. Healthcare facilities are implementing AI technologies through machine learning and deep learning systems to enhance their capabilities in detecting diseases which includes radiology and oncology and cardiology and pathology. 

The United Kingdom market is experiencing growth because government funding and support for digital health innovations. The National Health Service and other organizations are testing and implementing artificial intelligence technologies to enhance patient care and operational efficiency. The market gains advantages from partnerships between technology firms and research organizations and healthcare institutions. The market will experience some limitations because of data protection issues and regulatory difficulties and expensive system setup requirements. The market will grow extensively during the next few years because it will develop into a vital element for transforming the healthcare system in the United Kingdom.

Key Market Trends & Insights:

  • The medical field experiences its current transformation through the fast implementation of AI imaging tools which enable doctors to conduct radiology scans with higher speed and accuracy while decreasing their work demands and achieving better patient results throughout medical facilities. 
  • The rising use of AI in clinical decision support systems helps doctors improve their diagnostic performance through its capability to process extensive medical data which assists them in identifying diseases at earlier stages while providing them with superior treatment selection tools. 
  • The United Kingdom experiences enhanced AI innovation and deployment in diagnostic procedures through increasing partnerships among healthcare organizations and technology companies and institutions such as the National Health Service. 
  • The healthcare industry implements AI diagnostic solutions which provide predictive analytics and personalized treatment methods to meet the increasing need for early disease identification particularly in oncology and cardiology. 
  • The market for AI in healthcare experiences growth because of government initiatives and digital health transformation regulations yet data privacy problems and system integration difficulties and high initial costs continue to present challenges.

United Kingdom Artificial Intelligence In Diagnostics Market Segmentation

By Component

  • Software: The software segment dominates the market because AI algorithms are used throughout medical imaging analysis and clinical decision support systems and predictive diagnostic tests. The healthcare sector adopts new technologies because machine learning and cloud solutions and data analytics capabilities continue to develop, which results in better diagnostic outcomes and faster tests and more effective health operations.
  • Hardware: The hardware category comprises all AI diagnostic tools and processors and imaging devices that medical facilities need to perform their advanced computational tasks. The market expansion occurs because hospitals and diagnostic centers adopt more advanced imaging systems and edge computing technology, but the process takes longer because of the expenses and infrastructure needs which exceed what medical facilities require for software implementation.

United Kingdom Artificial Intelligence In Diagnostics Market Component

To learn more about this report,  PDF Icon Download Free Sample Report

By Application

  • Radiology: The application area of radiology uses AI technology for medical image analysis which includes X-ray and MRI and CT scan examination. The system improves detection performance while decreasing time needed for image interpretation and it helps radiologists handle large amounts of medical images which healthcare organizations use.
  • Pathology: AI technology enables pathologists to perform digital slide analysis while the system automatically identifies disease patterns within tissue specimens. The technology enhances diagnostic accuracy by minimizing mistakes from human operators while it expedites laboratory operations which handle large quantities of testing and intricate case examinations.
  • Cardiology: AI technology assists cardiologists with ECG data analysis and imaging scan evaluation and patient record examination to identify heart diseases at an early stage. The system enables risk forecasting together with ongoing assessment and customized treatment development which empowers doctors to enhance patient results and better handle cardiovascular disease.
  • Oncology: AI technology brought about significant changes to oncology through its ability to detect cancer at initial stages and classify tumors and determine optimal treatment methods. The system analyzes extensive datasets which contain both imaging and genomic data to enable precision medicine methods which result in better survival outcomes and improved decision-making processes for cancer diagnosis and treatment.

By End-User

  • Hospitals: The complete hospital system functions as the main customer sector because hospitals need to treat many patients and their medical system capacity. The National Health Service and other organizations use artificial intelligence technology to improve their diagnostic processes and decrease clinician work requirements and deliver better patient care through speedier and more precise diagnostic results. 
  • Diagnostic Centers: Diagnostic Centers:Diagnostic centers are increasingly integrating AI technologies to improve testing accuracy and reduce turnaround times. The facilities use automation and advanced analytics technologies to handle increasing diagnostic work while providing accurate results to patients and healthcare providers.

Country Insights

The United Kingdom Artificial Intelligence in Diagnostics market receives strong backing from its established healthcare system which the government supports through its digital transformation initiatives. The National Health Service has begun using AI technology in its diagnostic processes to manage increasing patient flow, reduce wait times, and boost operational performance. The United Kingdom has emerged as a prominent center for AI-based healthcare solutions because of its substantial health technology research funding and its rising number of AI startups and research partnerships.

The major urban centers of London, Cambridge and Oxford create a strong innovation base because of their academic institutions and research centers and funding resources. AI-based diagnostic tools are being rapidly implemented in hospitals and specialized clinics throughout these areas. The rest of the country is moving towards technology adoption which national healthcare strategies support to close healthcare gaps and provide advanced diagnostic services throughout the United Kingdom.

Recent Development News

In March 2026, Seed Capital Solutions plc announced acquisition progress. The company provided an update on its planned acquisition of an AI diagnostics business, with audit processes underway and completion targeted by end-April 2026.

In April 2026, Seed Capital Solutions plc reported acquisition advancement. The firm confirmed continued progress toward finalizing its AI diagnostics acquisition as part of its broader strategy to expand into healthcare AI ahead of its planned AIM market move.

Report Metrics

Details

Market size value in 2025

USD 123.4 Million

Market size value in 2026

USD 151.54 Million

Revenue forecast in 2033

USD 641.69 Million

Growth rate

CAGR of 22.90% from 2026 to 2033

Base year

2025

Historical data

2021 – 2024

Forecast period

2026 – 2033

Report coverage

Revenue forecast, competitive landscape, growth factors, and trends

Country scope

United Kingdom

Key company profiled

Siemens Healthineers AG, GE HealthCare Technologies Inc., Philips Healthcare, IBM Corporation, NVIDIA Corporation, Microsoft Corporation, Google LLC, Aidoc Medical Ltd., Zebra Medical Vision Ltd., PathAI Inc., Tempus Labs Inc., Butterfly Network Inc., Viz.ai Inc., AliveCor Inc., Caption Health Inc.

Customization scope

Free report customization (country, regional & segment scope). Avail customized purchase options to meet your exact research needs.

Report Segmentation

By Component (Software, Hardware), By Application (Radiology, Pathology, Cardiology, Oncology), By End-User (Hospitals, Diagnostic Centers).

Key United Kingdom Artificial Intelligence In Diagnostics Market Company Insights

The United Kingdom AI in Diagnostics market experiences rapid growth because healthcare systems use digital technologies and people need fast and precise disease identification and medical facilities use machine learning methods for their operational procedures. International companies such as Siemens Healthineers AG and GE HealthCare Technologies Inc. and Philips Healthcare use their advanced AI‑enabled imaging solutions with diagnostic platforms to enhance their ability to deliver accurate medical results while reducing operational times and improving their work processes. The companies develop AI‑based imaging technologies and predictive analytics systems and decision support tools which help hospitals and diagnostic centers in the UK enhance their diagnostic accuracy and operational functions.

The UK diagnostic AI market depends on major technology companies which include IBM Corporation and NVIDIA Corporation and Microsoft Corporation and Google LLC for their cloud platforms and AI frameworks and advanced computing capabilities. The healthcare industry uses IBM and Microsoft scalable cloud solutions with their analytics platforms to manage healthcare data while NVIDIA provides GPUs and AI toolkits which help diagnostic algorithm training and inference processes. Google uses its AI research together with DeepMind division projects on medical imaging and predictive care to show how deep learning models function in actual clinical environments. The companies provide essential technologies for AI diagnostics system development through their healthcare provider partnerships which support ongoing progress in algorithm performance and operational process integration.

Company List

United Kingdom Artificial Intelligence In Diagnostics Market Report Segmentation

By Component

  • Software
  • Hardware

By Application

  • Radiology
  • Pathology
  • Cardiology
  • Oncology

By End-User

  • Hospitals
  • Diagnostic Centers

Frequently Asked Questions

Find quick answers to common questions.

  • Siemens Healthineers AG
  • GE HealthCare Technologies Inc.
  • Philips Healthcare
  • IBM Corporation
  • NVIDIA Corporation
  • Microsoft Corporation
  • Google LLC
  • Aidoc Medical Ltd.
  • Zebra Medical Vision Ltd.
  • PathAI Inc.
  • Tempus Labs Inc.
  • Butterfly Network Inc.
  • Viz.ai Inc.
  • AliveCor Inc.
  • Caption Health Inc.

Recently Published Reports

Our Clients

client-logo_(1).jpg
client-logo.jpg
client-logo1.jpg
client-logo2.jpg
client-logo3.jpg
client-logo7.jpg
client-logo11.jpg
client-logo31.jpg